Last reviewed · How we verify
NCT01655784: FEAT
Framing Eighteen Coils in Cerebral Aneurysms Trial
NA trial testing Coil Embolization with larger Diameter Coils in Cerebral Aneurysm in 651 participants. Completed in 19 February 2024.
19 February 2024
Quick facts
| Lead sponsor | Vanderbilt University Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 651 |
| Start date | 4 December 2012 |
| Primary completion | 19 February 2024 |
| Estimated completion | 19 February 2024 |
| Sites | 24 locations across United States |
Drugs / interventions tested
- Coil Embolization with larger Diameter Coils
- Coil Embolization with Standard Diameter Coils
Conditions studied
- Cerebral Aneurysm — all drugs for Cerebral Aneurysm →
Sponsor
Vanderbilt University Medical Center
Who can join
Adults 18 to 80, any sex, with Cerebral Aneurysm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial is being conducted in order to compare angiographic outcomes in patients receiving 0.014-0.0155" platinum framing and filling coils (larger diameter coils) versus those treated solely with coils less than 0.014" (with a standard diameter). Hypothesis: Angiographic occlusion at follow-up imaging will be more frequent in patients receiving 0.014-0.0155" platinum coils during embolization compared to those receiving smaller-diameter coils.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT01655784
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebral Aneurysm
Currently open trials in the same condition.
- NCT06201598 — Prospective, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Endovascular Treatment in Patient · recruiting
- NCT05864300 — Impact of Neurochecks on Sleep in Critically Ill Adults · NA · active not recruiting
- NCT04141020 — Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms · Phase 2 · recruiting
- NCT05961748 — Registry of Multicenter Brain-Heart Comorbidity in China · recruiting
- NCT06456814 — Epidemiological Insights Into the Formation, Progression, and Rupture of Intracranial Aneurysms: A Retrospective, Multi- · recruiting
Other Vanderbilt University Medical Center trials
Trials by the same sponsor.
- NCT07005037 — Swallowing Impairments in ICU Survivors and Community-Dwelling Adults · not yet recruiting
- NCT07527273 — Cognitive Enhancement in Recurrent Depression (The COG-D-R Study) · NA · not yet recruiting
- NCT07295288 — Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis · Phase 4 · not yet recruiting
- NCT07431541 — Topical Carboxytherapy Paste Following Microneedling · Phase 1, PHASE2 · not yet recruiting
- NCT07224711 — The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01655784 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vanderbilt University Medical Center
- Last refreshed: 6 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01655784.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing